Delivery Order SPE2DB22D3016-SPE2DB25FAUL1
Award Date
4/22/25
Potential Completion Date
5/13/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $30,567.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a period of performance through March 7, 2025. This delivery order is issued under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $3,518.40 order is for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The potential value of this delivery order is $14,073.60, with a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this contract does not have a set-aside designation. The...
The U.S. Defense Logistics Agency (DLA) awarded a $9,367.94 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 mg. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,935,388 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a ceiling value of $7,641.98 and a performance period ending on May 7, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,283.96 fixed-price contract is for the delivery of the prescription medication NUBEQA 300 MG TABLET 120S. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This allows...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,283.96 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the supply of NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 19, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The delivery order, valued at $9,367.94, is a firm fixed-price contract with an ultimate completion date of August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this contract. The award is not associated with a set-aside program. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $7,641.98 and a period of performance ending on May 14, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...